Page 132 - Advances in Forensic Applications of Mass Spectrometry - Jehuda Yinon

1522_C02.fm Page 115 Wednesday, November 12, 2003 9:36 AM

47. O’Neal C.L. and Poklis A. Simultaneous determination of acetylcodeine,
monoacetylmorphine and other opiates in urine by GC-MS. J. Anal. Toxicol.
21, 427, 1997.
48. O’Neal C.L. and Poklis A. The detection of acetylcodeine and 6-acetylmor-
phine in opiate-positive urines. Forensic Sci. Int. 95, 1, 1998.
49. Staub C., Marset M., Mino A., and Mangin P. Detection of acetylcodeine in
urine as an indicator of illicit heroin use: method validation and results of a
pilot study. Clin. Chem. 47, 301, 2001.
50. Bogusz M.J., Maier R.D., Erkens M., and Kohls U. Detection of non-prescrip-
tion heroin markers in urine with liquid chromatography-atmospheric pres-
sure chemical ionization mass spectrometry. J. Anal. Toxicol. 25, 431, 2001.
51. Gaulier J.M., Marquet P., Lacassie E., Dupuy J.L., and Lachatre G. Fatal
intoxication following self-administration of a massive dose of buprenor-
phine. J. Forensic Sci. 45, 226, 2000.
52. Polettini A. and Huestis M.A. Simultaneous determination of buprenorphine,
norbuprenorphine, and buprenorphine-glucuronide in plasma by liquid
chromatography-tandem mass spectrometry. J. Chromatogr. B 754, 447, 2001.
53. Moody D.E., Laycock J.D., Spanbauer A.C., Crouch D.J., Foltz R.L., Josephs J.L.,
and Bickel W.K. Determination of buprenorphine in human plasma by gas
chromatography-positive ion chemical ionization mass spectrometry and liq-
uid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 21, 406, 1997.
54. Moody D.E., Slawson M.H., Strain E.C., Laycock J.D., Spanbauer A.C., and
Foltz R.L. A liquid chromatographic-electrospray ionization tandem mass
spectrometric method for determination of buprenorphine, its metabolite
norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo
and in vitro metabolism studies. Anal. Biochem. 306, 31, 2002.
55. Hoja H., Marquet P., Verneuil B., Lofti H., Dupuy J.L, and Lachatre G. Deter-
mination of buprenorphine and norbuprenorphine in whole blood by liquid
chromatography-mass spectrometry. J. Anal. Toxicol. 21, 160, 1997.
56. Bogusz M.J., Maier R.D., Kruger K.D., and Kohls U. Determination of com-
mon drugs of abuse in body fluid using one isolation procedure and liquid
chromatography-atmospheric pressure chemical ionization mass spectrom-
etry. J. Anal. Toxicol. 22, 549, 1998.
57. Breindahl T. and Andreasen K. Validation of urine drug-of-abuse testing for
ketobemidone using thin-layer chromatography and liquid chromatography-
electrospray mass spectrometry. J. Chromatogr. B 736, 103, 1999.
58. Sundstrom I., Bondesson U., and Hedeland M. Identification of phase I and
phase II metabolites of ketobemidone in patient urine using liquid chromatog-
raphy-electrospray tandem mass spectrometry. J. Chromatogr. B 763, 121, 2001.
59. Sundstrom I., Hedeland M., Bondesson U., and Andren P.E. Identification of
glucuronide conjugates of ketobemidone and its phase I metabolites in
human urine utilizing accurate mass and tandem time-of-flight mass spec-
trometry. J. Mass Spectrom. 37, 14, 2002.

© 2004 by CRC Press LLC